In US Amwell floated recently at $18 a share after raising the ipo price from week b4 when they said it was around $14. Now it’s bid price at $35 as I write this. At this price I think it’s about valued close to 40 times it’s revenue. As per AFR article DCA be listing at 8.7 times revenue. So may be some value in this!!
https://www.fiercehealthcare.com/tech/telehealth-company-amwell-spikes-public-debut-outsized-742m-ipo
In US Amwell floated recently at $18 a share after raising the...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)